Ecolab (ECL) said Wednesday it has opened a new facility in King of Prussia, Pennsylvania, to assist biopharmaceutical companies and contract manufacturers with applications and process development of therapeutic molecules.
The site offers process development tools and chromatography columns for drug developers from the early stage of development to commercialization, the company said.
Ecolab said the lab is intended to help clients cut costs, streamline production, and prepare documentation for regulatory submission.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。